In ITT analysis , there was only weak evidence that those on reboxetine had a slightly worse outcome than those on citalopram [ adjusted difference in mean Beck Depression Inventory ( BDI ) scores : 1.19 , 95 % confidence interval ( CI ) -0.52 to 2.90 , p = 0.17 ] .